Birth size has been positively associated with age at menarche and height in adolescence and adulthood, but the relevant biological mechanisms remain unclear. Among 262 Norwegian term-born singleton girls, birth size measures (weight, length, ponderal index, head circumference and subscapular skin-fold thickness) were analysed in relation to adolescent hormone levels (oestradiol, prolactin, dehydroepiandrosterone sulphate, androstenedione and free testosterone index), age at menarche and adolescent (ages 12.7 -15.5 years) and body size (height, weight, body mass index and waist-to-hip ratio) using survival analysis and general linear modelling. The results were adjusted for gestational age at birth, age and menarcheal status at measurement in adolescence and maternal age at menarche. Birth weight, birth length and head circumference were positively associated with adolescent weight and height, and small birth size was associated with earlier age at menarche. Subscapular skin-fold thickness at birth was not associated with adolescent body size, but low fold-thickness was associated with earlier age at menarche. Measures of birth size were inversely related to circulating levels of dehydroepiandrosterone sulphate in adolescence, but there was no clear association with other hormones. These results suggest that physical and sexual development in puberty and adolescence is influenced by prenatal factors, and in combination, these factors may influence health and disease later in life. (Trichopoulos, 1990) has stimulated studies of birth size in relation to risk factors for BC (Okasha et al, 2003). Birth size is an indicator of foetal growth and may reflect intrauterine exposure to oestrogen, the key factor that was originally proposed to explain a possible association between intrauterine factors and adult BC (Trichopoulos, 1990). Studies have shown that relatively large birth size is associated with later age at menarche (Adair, 2001;Sloboda et al, 2007) and taller body height, both in adolescence (Pietiläinen et al, 2001;Romundstad et al, 2003) and in adulthood (Loos et al, 2002). Adult tallness is associated with higher BC risk, and the positive association between birth size and body height suggests that longitudinal growth in childhood and adolescence may be important determinants for subsequent BC (Michels and Willett, 2004). Birth size has also been inversely related to adrenal androgen production during childhood (Ong et al, 2004) and adolescence (Ibanez et al, 1999). Adult levels of both adrenal and gonadal androgens have been associated with BC risk (Kaaks et al, 2005a, b). The fact that small birth size is associated with earlier age at menarche and higher circulating levels of adrenal androgens cannot be easily reconciled with known BC risk factors, as small birth size may be related to reduced risk, and both early age at menarche and androgens are expected to increase risk.We have examined the relation between birth size characteristics and potential BC risk factors (ESHRE Capri Workshop Group, 2004),...